Stent leader Cordis in new patent move
This article was originally published in Clinica
Executive Summary
The highly profitable coronary stent market has again shown how litigious it can be, with Cordis adding Aterial Vascular Engineering and Boston Scientific to its patent lawsuit against Guidant.